Validation of the protein kinase PfCLK3 as a multi-stage cross species malarial drug target
M. Alam, A. Sanchez-Azqueta, O. Janha, E. Flannery, A. Mahindra, K. Mapesa, N. Brancucci, Y. Antonova-Koch, K. Crouch, N. V. Simwela, J. Akinwale, D. Mitcheson, L. Solyakov, K. Dudek, C. Jones, , A. Tobin
This study identifies PfCLK3 as a druggable target for malaria by showing its essential role in multiple parasite life stages across species.
bioRxiv · Aug 31, 2018 · PreprintMicrobiology